Accessibility Menu

Best Psychedelic Stocks to Buy in 2025

By Keith SpeightsUpdated Oct 6, 2025 at 5:07 PM | Fact-checked by Frank Bass

Key Points

  • Psychedelic stocks focus on hallucinogenic treatments for psychiatric disorders.
  • Top companies like Atai and Compass are progressing in phase 2 and 3 clinical trials.
  • Investing in these stocks is risky as none have yet reached the market or profitability.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.